Related Experiment Video
Updated: Dec 1, 2025

06:13
Introducing a Gene Knockout Directly Into the Amastigote Stage of Trypanosoma cruzi Using the CRISPR/Cas9 System
Published on: July 31, 2019
9.4K
Testing the CRISPR-Cas9 and glmS ribozyme systems in Leishmania tarentolae
Gino L Turra1, Luzia Schneider2, Linda Liedgens1
1Department of Parasitology, Ruprecht-Karls University, D-69120, Heidelberg, Germany; Faculty of Chemistry, TU Kaiserslautern, D-67663, Kaiserslautern, Germany.
Molecular and Biochemical Parasitology
|November 9, 2020
Summary
We evaluated CRISPR-Cas9 and glmS ribozyme systems for gene editing in Leishmania tarentolae. CRISPR-Cas9 enabled gene disruption, while glmS showed limited efficiency for gene knock-down.
Area of Science:
- * Molecular Biology
- * Parasitology
- * Genomics
Background:
- * Leishmania parasites are crucial pathogens and model organisms, but functional genomics studies are hindered by low-throughput gene manipulation technologies.
- * Existing methods for gene disruption and tagging in Leishmania are limited, and RNA interference components are absent, restricting essential gene characterization.
- * The development of efficient genetic tools is vital for advancing research in Leishmania biology and pathogenesis.
Purpose of the Study:
- * To assess the efficacy of the T7 RNA polymerase-dependent CRISPR-Cas9 system for gene disruption and tagging in the model parasite Leishmania tarentolae.
- * To evaluate the performance of the glmS ribozyme-based system for inducible gene knock-down in Leishmania tarentolae.
- * To compare the capabilities and limitations of CRISPR-Cas9 and glmS systems for genetic manipulation in Leishmania.
Main Methods:
- * CRISPR-Cas9 system was employed for the targeted deletion of reference genes (Pf16, adenine phosphoribosyltransferase, Erv).
- * glmS ribozyme system was utilized for both constitutive and inducible gene knock-down studies using episomal and chromosomal reporters.
- * Leishmania tarentolae strains were cultivated in various media (BHI, MEM, IMDM, McCoy's 5A) to optimize inducible knock-down conditions.
Main Results:
- * Successful deletion of genes encoding flagellar motility factor Pf16 and adenine phosphoribosyltransferase was achieved using CRISPR-Cas9, yielding immotile and drug-resistant parasites, respectively.
- * CRISPR-Cas9 mediated gene disruption was unsuccessful for the mitochondrial flavoprotein Erv gene.
- * Constitutive down-regulation of an episomal mCherry-glmS reporter was observed (40-60%) in standard BHI medium.
- * Inducible knock-down of the episomal reporter exceeded 70% in supplemented MEM medium, dependent on glucosamine concentration.
- * Chromosomal glmS-tagging of Pf16, adenine phosphoribosyltransferase, or Erv genes did not result in a detectable knock-down phenotype.
Conclusions:
- * The CRISPR-Cas9 system is effective for gene disruption and tagging in Leishmania tarentolae, offering a valuable tool for functional genomics.
- * The glmS system demonstrated limitations, achieving only moderate efficiencies for episomal knock-downs and failing to produce a detectable phenotype for chromosomal knock-downs.
- * Further optimization or alternative strategies are needed to enhance the efficiency and applicability of the glmS system for chromosomal gene knock-down in Leishmania.
Related Concept Videos
CRISPR/Cas9 Genome Editing
1.1K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
1.1K
CRISPR
55.6K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
55.6K

